What is Omeros's net margin?

Omeros (OMER) reported net margin of -136.6% in Q3 2021.

What does net margin mean?

Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Omeros OMER Net margin

Discontinued — last reported Q3 '21

Net margin at other companies

Nektar TherapeuticsNKTR

-284.2%+937pp

ImmunomeIMNM

-5,593.8%-11,284pp

Arcus BiosciencesRCUS

-156.4%-47.5pp

Dianthus TherapeuticsDNTH

-4,104.8%-7,304pp

AnaptysBio, Inc.ANAB

-49.9%-22.6pp

Spyre Therapeutics, Inc.SYRE

-52,939.7%-61,871pp

Other financials

Income statement

See full

Revenue$9.9M—

Gross profit$29.7M—

Operating income-$40.9M-9.2%

Net income$56.1M+268%

EPS (diluted)-$0.59-20.4%

Balance sheet

See full

Cash & equivalents$1.9M-55.3%

Total debt$13.5M-30.3%

Total equity-$63.3M+70.3%

Total assets$286.2M+21.7%

Cash flow

See full

Operating cash flow-$14.5M+59.5%

CapEx--100%

Free cash flow-$14.5M+59.6%

Valuation

See full

Market cap$775.86M+313%

P/S8.6×—

Profitability

See full

Gross margin98.9%—

Operating margin-181.8%—

FCF margin-121.6%—

Returns & leverage

See full

Return on equity86.6%—

Debt / equity0.3×-1.1×

Current ratio3×+1.9×

Where this comes from

Calculated from Omeros’s reported figures.

net income/total revenue=-136.6%

Based on trailing twelve months.

The official record: Omeros’s 10-Q, filed November 9, 2021, on SEC EDGAR. View the filing →

Ask your AI about Omeros's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Omeros's net margin?: Omeros (OMER) reported net margin of -136.6% in Q3 2021.
What does net margin mean?: Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.